Store-independent Orai1/3 channels activated by intracrine leukotrienec4

Role in neointimal hyperplasia

José C. González-Cobos, Xuexin Zhang, Wei Zhang, Brian Ruhle, Rajender K. Motiani, Rainer Schindl, Martin Muik, Amy M. Spinelli, Jonathan M. Bisaillon, Arti V. Shinde, Marc Fahrner, Harold A. Singer, Khalid Matrougui, Margarida Barroso, Christoph Romanin, Mohamed Trebak

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

RATIONALE: Through largely unknown mechanisms, Ca2+ signaling plays important roles in vascular smooth muscle cell (VSMC) remodeling. Orai1-encoded store-operated Ca2+ entry has recently emerged as an important player in VSMC remodeling. However, the role of the exclusively mammalian Orai3 protein in native VSMC Ca2+ entry pathways, its upregulation during VSMC remodeling, and its contribution to neointima formation remain unknown. OBJECTIVE: The goal of this study was to determine the agonist-evoked Ca2+ entry pathway contributed by Orai3; Orai3 potential upregulation and role during neointima formation after balloon injury of rat carotid arteries. METHODS AND RESULTS: Ca2+ imaging and patch-clamp recordings showed that although the platelet-derived growth factor activates the canonical Ca2+ release-activated Ca2+ channels via store depletion in VSMC, the pathophysiological agonist thrombin activates a distinct Ca2+-selective channel contributed by Orai1, Orai3, and stromal interacting molecule1 in the same cells. Unexpectedly, Ca2+ store depletion is not required for activation of Orai1/3 channel by thrombin. Rather, the signal for Orai1/3 channel activation is cytosolic leukotrieneC4 produced downstream thrombin receptor stimulation through the catalytic activity of leukotrieneC4 synthase. Importantly, Orai3 is upregulated in an animal model of VSMC neointimal remodeling, and in vivo Orai3 knockdown inhibits neointima formation. CONCLUSIONS: These results demonstrate that distinct native Ca 2+-selective Orai channels are activated by different agonists/pathways and uncover a mechanism whereby leukotrieneC4 acts through hitherto unknown intracrine mode to elicit store-independent Ca 2+ signaling that promotes vascular occlusive disease. Orai3 and Orai3-containing channels provide novel targets for control of VSMC remodeling during vascular injury or disease.

Original languageEnglish (US)
Pages (from-to)1013-1025
Number of pages13
JournalCirculation Research
Volume112
Issue number7
DOIs
StatePublished - Mar 29 2013
Externally publishedYes

Fingerprint

Vascular Smooth Muscle
Smooth Muscle Myocytes
Hyperplasia
Neointima
Vascular Diseases
Thrombin
Up-Regulation
Carotid Artery Injuries
Thrombin Receptors
Vascular System Injuries
Platelet-Derived Growth Factor
Animal Models
Proteins

Keywords

  • calcium signaling
  • ion channel
  • neointima formation
  • Orai1
  • Orai3
  • STIM1
  • vascular smooth muscle

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

González-Cobos, J. C., Zhang, X., Zhang, W., Ruhle, B., Motiani, R. K., Schindl, R., ... Trebak, M. (2013). Store-independent Orai1/3 channels activated by intracrine leukotrienec4: Role in neointimal hyperplasia. Circulation Research, 112(7), 1013-1025. https://doi.org/10.1161/CIRCRESAHA.111.300220

Store-independent Orai1/3 channels activated by intracrine leukotrienec4 : Role in neointimal hyperplasia. / González-Cobos, José C.; Zhang, Xuexin; Zhang, Wei; Ruhle, Brian; Motiani, Rajender K.; Schindl, Rainer; Muik, Martin; Spinelli, Amy M.; Bisaillon, Jonathan M.; Shinde, Arti V.; Fahrner, Marc; Singer, Harold A.; Matrougui, Khalid; Barroso, Margarida; Romanin, Christoph; Trebak, Mohamed.

In: Circulation Research, Vol. 112, No. 7, 29.03.2013, p. 1013-1025.

Research output: Contribution to journalArticle

González-Cobos, JC, Zhang, X, Zhang, W, Ruhle, B, Motiani, RK, Schindl, R, Muik, M, Spinelli, AM, Bisaillon, JM, Shinde, AV, Fahrner, M, Singer, HA, Matrougui, K, Barroso, M, Romanin, C & Trebak, M 2013, 'Store-independent Orai1/3 channels activated by intracrine leukotrienec4: Role in neointimal hyperplasia', Circulation Research, vol. 112, no. 7, pp. 1013-1025. https://doi.org/10.1161/CIRCRESAHA.111.300220
González-Cobos, José C. ; Zhang, Xuexin ; Zhang, Wei ; Ruhle, Brian ; Motiani, Rajender K. ; Schindl, Rainer ; Muik, Martin ; Spinelli, Amy M. ; Bisaillon, Jonathan M. ; Shinde, Arti V. ; Fahrner, Marc ; Singer, Harold A. ; Matrougui, Khalid ; Barroso, Margarida ; Romanin, Christoph ; Trebak, Mohamed. / Store-independent Orai1/3 channels activated by intracrine leukotrienec4 : Role in neointimal hyperplasia. In: Circulation Research. 2013 ; Vol. 112, No. 7. pp. 1013-1025.
@article{f0fa69c6666a4f22b38eb7222fea14f7,
title = "Store-independent Orai1/3 channels activated by intracrine leukotrienec4: Role in neointimal hyperplasia",
abstract = "RATIONALE: Through largely unknown mechanisms, Ca2+ signaling plays important roles in vascular smooth muscle cell (VSMC) remodeling. Orai1-encoded store-operated Ca2+ entry has recently emerged as an important player in VSMC remodeling. However, the role of the exclusively mammalian Orai3 protein in native VSMC Ca2+ entry pathways, its upregulation during VSMC remodeling, and its contribution to neointima formation remain unknown. OBJECTIVE: The goal of this study was to determine the agonist-evoked Ca2+ entry pathway contributed by Orai3; Orai3 potential upregulation and role during neointima formation after balloon injury of rat carotid arteries. METHODS AND RESULTS: Ca2+ imaging and patch-clamp recordings showed that although the platelet-derived growth factor activates the canonical Ca2+ release-activated Ca2+ channels via store depletion in VSMC, the pathophysiological agonist thrombin activates a distinct Ca2+-selective channel contributed by Orai1, Orai3, and stromal interacting molecule1 in the same cells. Unexpectedly, Ca2+ store depletion is not required for activation of Orai1/3 channel by thrombin. Rather, the signal for Orai1/3 channel activation is cytosolic leukotrieneC4 produced downstream thrombin receptor stimulation through the catalytic activity of leukotrieneC4 synthase. Importantly, Orai3 is upregulated in an animal model of VSMC neointimal remodeling, and in vivo Orai3 knockdown inhibits neointima formation. CONCLUSIONS: These results demonstrate that distinct native Ca 2+-selective Orai channels are activated by different agonists/pathways and uncover a mechanism whereby leukotrieneC4 acts through hitherto unknown intracrine mode to elicit store-independent Ca 2+ signaling that promotes vascular occlusive disease. Orai3 and Orai3-containing channels provide novel targets for control of VSMC remodeling during vascular injury or disease.",
keywords = "calcium signaling, ion channel, neointima formation, Orai1, Orai3, STIM1, vascular smooth muscle",
author = "Gonz{\'a}lez-Cobos, {Jos{\'e} C.} and Xuexin Zhang and Wei Zhang and Brian Ruhle and Motiani, {Rajender K.} and Rainer Schindl and Martin Muik and Spinelli, {Amy M.} and Bisaillon, {Jonathan M.} and Shinde, {Arti V.} and Marc Fahrner and Singer, {Harold A.} and Khalid Matrougui and Margarida Barroso and Christoph Romanin and Mohamed Trebak",
year = "2013",
month = "3",
day = "29",
doi = "10.1161/CIRCRESAHA.111.300220",
language = "English (US)",
volume = "112",
pages = "1013--1025",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Store-independent Orai1/3 channels activated by intracrine leukotrienec4

T2 - Role in neointimal hyperplasia

AU - González-Cobos, José C.

AU - Zhang, Xuexin

AU - Zhang, Wei

AU - Ruhle, Brian

AU - Motiani, Rajender K.

AU - Schindl, Rainer

AU - Muik, Martin

AU - Spinelli, Amy M.

AU - Bisaillon, Jonathan M.

AU - Shinde, Arti V.

AU - Fahrner, Marc

AU - Singer, Harold A.

AU - Matrougui, Khalid

AU - Barroso, Margarida

AU - Romanin, Christoph

AU - Trebak, Mohamed

PY - 2013/3/29

Y1 - 2013/3/29

N2 - RATIONALE: Through largely unknown mechanisms, Ca2+ signaling plays important roles in vascular smooth muscle cell (VSMC) remodeling. Orai1-encoded store-operated Ca2+ entry has recently emerged as an important player in VSMC remodeling. However, the role of the exclusively mammalian Orai3 protein in native VSMC Ca2+ entry pathways, its upregulation during VSMC remodeling, and its contribution to neointima formation remain unknown. OBJECTIVE: The goal of this study was to determine the agonist-evoked Ca2+ entry pathway contributed by Orai3; Orai3 potential upregulation and role during neointima formation after balloon injury of rat carotid arteries. METHODS AND RESULTS: Ca2+ imaging and patch-clamp recordings showed that although the platelet-derived growth factor activates the canonical Ca2+ release-activated Ca2+ channels via store depletion in VSMC, the pathophysiological agonist thrombin activates a distinct Ca2+-selective channel contributed by Orai1, Orai3, and stromal interacting molecule1 in the same cells. Unexpectedly, Ca2+ store depletion is not required for activation of Orai1/3 channel by thrombin. Rather, the signal for Orai1/3 channel activation is cytosolic leukotrieneC4 produced downstream thrombin receptor stimulation through the catalytic activity of leukotrieneC4 synthase. Importantly, Orai3 is upregulated in an animal model of VSMC neointimal remodeling, and in vivo Orai3 knockdown inhibits neointima formation. CONCLUSIONS: These results demonstrate that distinct native Ca 2+-selective Orai channels are activated by different agonists/pathways and uncover a mechanism whereby leukotrieneC4 acts through hitherto unknown intracrine mode to elicit store-independent Ca 2+ signaling that promotes vascular occlusive disease. Orai3 and Orai3-containing channels provide novel targets for control of VSMC remodeling during vascular injury or disease.

AB - RATIONALE: Through largely unknown mechanisms, Ca2+ signaling plays important roles in vascular smooth muscle cell (VSMC) remodeling. Orai1-encoded store-operated Ca2+ entry has recently emerged as an important player in VSMC remodeling. However, the role of the exclusively mammalian Orai3 protein in native VSMC Ca2+ entry pathways, its upregulation during VSMC remodeling, and its contribution to neointima formation remain unknown. OBJECTIVE: The goal of this study was to determine the agonist-evoked Ca2+ entry pathway contributed by Orai3; Orai3 potential upregulation and role during neointima formation after balloon injury of rat carotid arteries. METHODS AND RESULTS: Ca2+ imaging and patch-clamp recordings showed that although the platelet-derived growth factor activates the canonical Ca2+ release-activated Ca2+ channels via store depletion in VSMC, the pathophysiological agonist thrombin activates a distinct Ca2+-selective channel contributed by Orai1, Orai3, and stromal interacting molecule1 in the same cells. Unexpectedly, Ca2+ store depletion is not required for activation of Orai1/3 channel by thrombin. Rather, the signal for Orai1/3 channel activation is cytosolic leukotrieneC4 produced downstream thrombin receptor stimulation through the catalytic activity of leukotrieneC4 synthase. Importantly, Orai3 is upregulated in an animal model of VSMC neointimal remodeling, and in vivo Orai3 knockdown inhibits neointima formation. CONCLUSIONS: These results demonstrate that distinct native Ca 2+-selective Orai channels are activated by different agonists/pathways and uncover a mechanism whereby leukotrieneC4 acts through hitherto unknown intracrine mode to elicit store-independent Ca 2+ signaling that promotes vascular occlusive disease. Orai3 and Orai3-containing channels provide novel targets for control of VSMC remodeling during vascular injury or disease.

KW - calcium signaling

KW - ion channel

KW - neointima formation

KW - Orai1

KW - Orai3

KW - STIM1

KW - vascular smooth muscle

UR - http://www.scopus.com/inward/record.url?scp=84876409555&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876409555&partnerID=8YFLogxK

U2 - 10.1161/CIRCRESAHA.111.300220

DO - 10.1161/CIRCRESAHA.111.300220

M3 - Article

VL - 112

SP - 1013

EP - 1025

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 7

ER -